The 2026 edition of Advances in research for Charcot-Marie-Tooth disease (CMT)
AFM-Telethon has released the latest edition of its comprehensive document “Advances in Charcot-Marie-Tooth Disease”, offering patients, advocacy groups, and clinicians…
AFM-Telethon has released the latest edition of its comprehensive document “Advances in Charcot-Marie-Tooth Disease”, offering patients, advocacy groups, and clinicians…
How a new study on rare disease advocacy groups reinforces the core mission of the European CMT Federation to bridge…
What is the EURORDIS Rare Barometer Survey on Mental Health? Rare Barometer is an independent, non-profit survey initiative created by…
The European Charcot-Marie-Tooth Federation (ECMTF) highlights a pivotal step forward in the pursuit of effective treatments for Charcot-Marie-Tooth disease (CMT)….
The development of new therapies is a highly structured and collaborative scientific process that requires significant time and investment to…
Why CMT must be part of the next European rare disease agenda Rare diseases remain one of Europe’s most complex…
The European CMT Federation (ECMTF) welcomes the addition of Muskelsvindfonden, the Danish Muscular Dystrophy Association, to its network. The organization…
Discover the deliverables and concrete actions stemming from the second European CMT Specialists Conference
The European CMT Federation is delighted to officially welcome Qianlixing CMT Support Home as our newest Associate Member. This collaboration…
A Comprehensive Analysis of the 2026 EURO-NMD Webinar Series on Charcot-Marie-Tooth Disease and the Structural Framework of Neuromuscular Education in…
The European CMT community welcomes a definitive new scientific review authored by world-leading experts from the ECRA Board. In January…
A Comprehensive Report from the 2nd European CMT Specialist Conference The 2nd European CMT Specialist Conference was a landmark event,…